乙酸铬,Chromic acetate

产品编号:BJHY-C10885| CAS NO:1066-30-4| MDL NO:Null,without related properties.| 分子式:C6H906Cr·6H2O; Cr(CH3COO)3·6H2O| 分子量:229.13

Chromium(III) (acetate) (Chromic acetate) 是一种离子交联剂。

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
BJHY-C10885
379.00 杭州 北京(现货)
BJHY-C10885
899.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

产品名称乙酸铬
英文名称Chromic acetate
CAS编号1066-30-4
产品描述Chromium(III) (acetate) (Chromic acetate) 是一种离子交联剂。
产品沸点117.1ºC at 760 mmHg
产品密度1,28 g/cm3
产品闪点40ºC
精确质量228.980423
PSA78.90000
LogP0.04140
外观性状淡灰色绿色至带蓝色的绿色粉末
溶解性slightly soluble
溶解性数据
In Vitro: 

DMSO : 14.29 mg/mL (62.37 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 4.3643 mL 21.8217 mL 43.6433 mL
5 mM 0.8729 mL 4.3643 mL 8.7287 mL
10 mM 0.4364 mL 2.1822 mL 4.3643 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 1.43 mg/mL (6.24 mM); Clear solution

    此方案可获得 ≥ 1.43 mg/mL (6.24 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 14.3 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH₂O 中,得到澄清透明的生理盐水溶液
  • 2.

    请依序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 1.43 mg/mL (6.24 mM); Clear solution

    此方案可获得 ≥ 1.43 mg/mL (6.24 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 14.3 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

    将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中,再用生理盐水定容至 10 mL,完全溶解,澄清透明
*以上所有助溶剂都可在西域网站选购。
稳定性

易溶于水。本品实际是水合醋酸盐[Cr(H2O)6](CH3COO)3。

储存条件

密封干燥储存。

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


风险声明 (欧洲) R36/37/38
安全声明 (欧洲) S26-S36/37/39
危险品运输编码 UN 9101

Section 1: Product Identification
Chemical Name:Chromium (III) acetate solution, 11.2-11.8% Cr
CAS Registry Number:1066-30-4
Formula:Cr(OOCCH3)3
EINECS Number:none
Chemical Family:metal acetate salt
Synonym:Chromic acetate (III), Chromium triacetate, Acetic acid, chromium (III) salt

Section 2: Composition and Information on Ingredients
IngredientCAS NumberPercentACGIH (TWA)OSHA (PEL)
Title Compound1066-30-450%0.5mg/m30.5mg/m3
water7732-18-550%no datano data

Section 3: Hazards Identification
Emergency Overview:Irritating to eyes and skin. May be harmful if swallowed. Possible risk of irreversible effects.
Primary Routes of Exposure:Ingestion, eyes, inhalation
Eye Contact:Causes slight to mild irritation of the eyes.
Skin Contact:Causes slight to mild irritation of the skin.
Inhalation:Material is an aqueous solution. Inhalation is not applicable.
Mae harmful if swallowed. Ingestion may cause gastrointestinal distress, burning of throat, dizziness and
Ingestion:
weakness.
Acute Health Affects:Irritating to skin, eyes and respiratory tract. May be harmful if swallowed.
Chronic Health Affects:Possible risk of irreversible effects.
NTP:Yes
IARC:Yes
OSHA:No

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
Inhalation:
in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point:none
Autoignition Temperature:none
Explosion Limits:none
Extinguishing Medium:carbon dioxide, dry powder or foam
If involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure self-contained
Special Fire Fighting Procedures:
breathing apparatus and full protective clothing.
Hazardous Combustion andIf involved in a fire this material may emit toxic organic fumes.
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
Spill and Leak Procedures:Small spills can be absorbed in vermiculite or other suitable adsorbent.

SECTION 7: Handling and Storage
Handling and Storage:Store in a tightly sealed container.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection:Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection:Wear protective clothing and gloves.
Ventilation:If possible, handle the material in an efficient fume hood.
Respirator:No respirator required.
Ventilation:If possible, handle the material in an efficient fume hood.
Additional Protection:No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form:liq.
Molecular Weight:229.13
Melting Point:no data
Boiling Point:no data
Vapor Pressure:no data
Specific Gravity:1.28
Odor:none
Solubility in Water:material is an aqueous sol.

SECTION 10: Stability and Reactivity
Stability:air and moisture stable liquid
Hazardous Polymerization:no hazardous polymerization
Conditions to Avoid:none
Incompatibility:none
Decomposition Products:Carbon dioxide, carbon monoxide, organic vapors, and metal oxides

SECTION 11: Toxicological Information
Intravenous (mouse); LDLo: 2290 mg/kg. Intravenous (rabbit); LDLo:1604 mg/kg. Intravenous (frog); LDLo:
6185 mg/kg. Implant (rat); TDLo: 1000 mg/kg/56W-I. Bacteria-Escherichia coli; Mutation in microorganisms: 16
RTECS Data:mmol/L. Bacteria-Escheichia coli; DNA repair: 93 ug/well. Bacteria-Bacillus subtilis; DNA repair: 160 mmol/L.
Human Leukocyte; Cytogenetic analysis: 16 umol/L. Hamster Ovary; Cytogenetic analysis: 150 mg/L. Hamster
Ovary; Mutation in mammalian somatic cells: 200 umol/L.
Carcinogenic Effects:No data available
Mutagenic Effects:Possible mutagen
Tetratogenic Effects:No data available

SECTION 12: Ecological Information
Ecological Information:No information available

SECTION 13: Disposal Considerations
Disposal:Dispose of according to local, state and federal regulations.

SECTION 14: Transportation
Shipping Name (CFR):Non-hazardous
Hazard Class (CFR):NA
Additional Hazard Class (CFR):NA
Packaging Group (CFR):NA
UN ID Number (CFR):NA
Shipping Name (IATA):Non-hazardous
Hazard Class (IATA):NA
Additional Hazard Class (IATA):NA
Packaging Group (IATA):NA
UN ID Number (IATA):NA

SECTION 15: Regulatory Information
TSCA:Listed in the TSCA inventory
SARA (Title 313):Title compound see Category Code N090 for reporting.
Second Ingredient:none


SECTION 16 - ADDITIONAL INFORMATION
N/A

~%

1066-30-4结构式

1066-30-4

文献:EP2039673 A1, ; Page/Page column 12 ;

~%

1066-30-4结构式

1066-30-4

文献:Journal of the American Chemical Society, vol. 33, p. 702

~%

1066-30-4结构式

1066-30-4

文献:Journal of Catalysis, , vol. 105, p. 249 - 253

~%

1066-30-4结构式

1066-30-4

文献:Journal fuer Praktische Chemie (Leipzig), , vol. 4, p. 211 - 226 Cr: MVol.B, 133, page 274 - 275

~%

1066-30-4结构式

1066-30-4

文献:Journal of the Chemical Society, Dalton Transactions: Inorganic Chemistry (1972-1999), , p. 734 - 740

~%

1066-30-4结构式

1066-30-4

文献:Monatshefte fuer Chemie, vol. 3, p. 252

服务热线

13911702513
18601927057

微信客服